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The role of parental hypertension in the frequency and age of
diagnosis of hypertension in offspring with autosomal-dominant
polycystic kidney disease.
Background. Hypertension in autosomal-dominant polycys-
tic kidney disease (ADPKD) patients is associated with more
rapid progression of renal disease and a high incidence of
left ventricular hypertrophy (LVH). The present study was
undertaken to examine the role of parental hypertension in
the occurrence of hypertension in 475 ADPKD offspring.
Methods. Adult subjects participating in an ongoing study
of the natural history of ADPKD were included in the analysis
if they were diagnosed with ADPKD, had a known affected
parent, and knew the hypertensive status of both parents.
Results. When the affected parent was hypertensive, the
ADPKD male (82% versus 62%, P  0.05) and female (61%
versus 37%, P  0.005) offspring had a significantly higher
frequency of hypertension than when the ADPKD-affected
parent was normotensive. The median age of diagnosis of hy-
pertension was also significantly earlier in both male (33 years
versus 40 years, P 0.05) and female (38 years versus 50 years,
P  0.05) ADPKD patients when their affected parents were
hypertensive as compared with normotensive. These effects of
hypertension in the affected parent on hypertension in the
ADPKD offspring were independent of age, renal volume, and
renal function in the offspring. Hypertension in unaffected
parents also increased the frequency of hypertension in the
ADPKD female (69% versus 53%, P  0.01), but not male
(89% versus 77%, NS) subjects.
Conclusion. The results indicate that parental hypertension
influences the frequency of hypertension in ADPKD patients.
Autosomal-dominant polycystic kidney disease
(ADPKD) has been demonstrated to be a monogenic
disorder with gene mutations in either chromosome 16
(type 1), chromosome 4 (type 2), or possibly a third, unde-
termined chromosome [1–7]. Affected members of a sin-
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gle family thus have the same genetic mutation. Never-
theless, substantial phenotypic variability has been shown
to occur between ADPKD members of the same family
[8, 9]. Such variability could be due to age, gender, envi-
ronmental factors, and/or modifying genes.
Hypertension occurs much earlier in ADPKD than in
patients with essential hypertension, diagnosed in 71%
of male and 46% of female ADPKD patients by age
40 years (unpublished data) in contrast to 31% of male
and 13% of female patients in the general population
[10]. Moreover, hypertension is present in 50% to 60%
of ADPKD patients when their glomerular filtration rates
(GFR) are well preserved (GFR 75 mL/min/1.73 m2)
[11, 12]. Hypertension in ADPKD patients is associated
with larger renal volumes, more rapid progression to
end-stage renal failure (ESRD), left ventricular hyper-
trophy (LVH), and occurs more frequently in ADPKD
males than females [11, 13]. In both males and females
with ADPKD, stable renal function for greater than
5 years has been observed, independent of age or gender,
when blood pressure remains normal in the absence of
antihypertensive therapy [14]. The present study was
undertaken to examine the hypothesis that the occur-
rence of hypertension in both affected and unaffected
parents influences the frequency of hypertension in
ADPKD offspring.
METHODS
Study subjects were chosen from participants in the
University of Colorado Health Sciences Center (UCHSC)
polycystic kidney disease (PKD) Research Project from
1985 to 2001. The study was approved by the Colorado
Multiple Institutional Review Board, and all subjects
provided informed consent. Subjects were chosen if they
had ADPKD (defined as more than five renal cysts bilat-
erally by ultrasound), had a known affected parent, knew
the hypertensive status of both parents, and had a com-
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plete study visit, including a standardized history and
physical examination, several blood pressure determina-
tions in various positions, including sitting (mean of 16
measurements), renal ultrasound with determination of
renal volume, two 24-hour urine collections for protein
and creatinine, and blood drawn for routine chemistries
and genetic studies. GFR was calculated by the MDRD
formula [15]. Hypertension in the study subjects was
defined as a history of hypertension and presently on anti-
hypertensive medications, or as having more than 50%
of either systolic or diastolic in-patient blood pressure
measurements greater than 140 or 90 mm Hg, respec-
tively. Subjects with no previous diagnosis of hyperten-
sion who were taking antihypertensive medications for
other reasons were excluded. Antihypertensive therapy
was determined by the subjects’ primary care physicians
and not by the investigators. The age of diagnosis of hyper-
tension was defined as either the age at which the study
subject reported first being diagnosed with hypertension
or, if the subject had no previous diagnosis of hyperten-
sion, the age at study visit when the blood pressures
were greater than 140/90 mm Hg. The subject was consid-
ered to be normotensive up to the age of study visit, if
the subject had blood pressures less than 140/90 mm Hg
at the study visit and was not on antihypertensive medi-
cation. Subjects were questioned as to the hypertensive
status of their parents; subjects who were unsure of the
hypertensive status of either parent were not included
in this analysis. The age of diagnosis of hypertension in
the parents was not determined.
Data are reported as the mean  standard deviation,
unless otherwise noted. Median values are followed by
the 95% confidence interval. P values less than 0.05 are
considered statistically significant. Categorical variables
were compared between groups using chi-square analy-
sis. Continuous variables were compared between groups
using unpaired Student t tests. Survival analysis was per-
formed using the Kaplan-Meier method, with survival
curves compared using the log-rank test. Multivariate
analysis was performed using logistic regression to model
the probability of hypertension in the offspring given the
presence or absence of hypertension in the affected or
unaffected parent, and the age, body mass index, and
24-hour urinary sodium excretion (as a surrogate for
sodium intake) of the offspring.
RESULTS
Study population
Seven hundred and three adults (18 years) from 387
families participated in the UCHSC Research Project
from 1985 to 2001. Of these, 475 from 237 families, 175
men and 300 women, met the study criteria. One hun-
dred sixty-eight subjects from 60 families were classified
as PKD type 1 (PKD1), 22 subjects from two families
were classified as PKD type 2 (PKD2), and 285 subjects
from 175 families did not have their linkage status deter-
mined.
Characteristics of male and female ADPKD subjects
The age of the subjects at the time of study visit was
comparable for the male and female subjects (40  11
versus 40  11 years, NS). The male ADPKD patients,
however, had a significantly greater incidence of hyper-
tension than the female ADPKD subjects (80% versus
58%, P  0.0001). Table 1 shows the significant differ-
ences between male and female ADPKD subjects with
respect to median age of diagnosis of hypertension, mean
renal volumes, blood pressures, and urinary protein ex-
cretion. The GFRs using the MDRD formula were, how-
ever, comparable between male and female ADPKD
patients when corrected for body surface area (56 
29 mL/min/1.73 m2 versus 60  29 mL/min/1.73 m2, NS).
Figure 1 shows the significant difference in age at diagno-
sis of hypertension between male and female subjects
with ADPKD. Thus, at the same study age and compara-
ble renal functions, there were substantial differences
between male and female ADPKD subjects. Subsequent
analyses were therefore undertaken separately for male
and female ADPKD subjects.
Characteristics of male and female ADPKD
subjects with respect to affected ADPKD
parents’ blood pressure status
When the affected ADPKD parent was hypertensive,
the ADPKD male offspring had a significantly greater in-
cidence of hypertension than when the affected ADPKD
parent was normotensive (82% versus 62%, P  0.05)
(Fig. 2). In addition, as shown in Figure 3A, the median
age of diagnosis of hypertension was significantly earlier
when the affected ADPKD parent was hypertensive.
Since hypertension is more common in males than fe-
males with ADPKD, it was not surprising that the hyper-
tensive affected parents were fathers more often than
the normotensive affected parents (58% versus 29%,
P  0.01).
Analysis of the female ADPKD subjects with respect
to their affected parents’ blood pressure status yielded
similar results as the male ADPKD subjects. When the af-
fected ADPKD parent was hypertensive as compared
to normotensive, the ADPKD female was significantly
more likely to be hypertensive (61% versus 37%, P 
0.005) (Fig. 2), and have an earlier age of diagnosis of
hypertension (Fig. 3B). Again, the hypertensive affected
parents were more often fathers than the normotensive
affected parents (53% versus 44%); however, this differ-
ence did not reach statistical significance.
There were no differences in renal volume, urinary
protein excretion or GFR, in either males or females,
when comparing those whose parents were or were not
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Table 1. Characteristics of male and female autosomal-dominant polycystic kidney disease (ADPKD) subjects
Male Female P value
Number 175 300 —
Age at visit years 4011 4011 NS
Hypertension 80% 58% 0.0001
Previous diagnosis of hypertension 72% 55% 0.0005
Hypertension diagnosed at visit 8% 3% 0.05
Mean age at diagnosis of hypertension years 3210 3411 NS
Median age at diagnosis of hypertension years (95% CI) 32 (30–33) 34 (33–35) 0.005
Systolic blood pressure mm Hg 13414 12714 0.0001
Diastolic blood pressure mm Hg 8611 819 0.0001
Mean arterial pressure mm Hg 10211 9610 0.0001
Systolic blood pressure (hypertension only)a mm Hg 13615 13115 0.005
Diastolic blood pressure (hypertension only) mm Hg 8811 839 0.0001
Mean arterial pressure (hypertension only) mm Hg 10411 9910 0.0001
Mean renal volume cm3 1082803 686476 0.0001
Mean renal volume cm3 [corrected for body surface area
(m2) (least squares means)] 99856 74640 0.001
Urinary protein excretion mg/24 hour 380544 243391 0.005
Serum creatinine mg/dL 2.11.5 1.51.2 0.0001
Glomerular filtration rate mL/min/1.73 m2 5629 6029 NS
Height cm 1818 1657 0.0001
Weight kg 8714 7318 0.0001
Body mass index kg/m2 26.54.4 26.76.6 NS
Urinary sodium excretion mmol/24 hours 20665 16054 0.0001
a Only those subjects with hypertension were used
Fig. 1. Kaplan-Meier survival curves for age at diagnosis of hyperten-
sion in 175 male and 300 female subjects with autosomal-dominant
polycystic kidney disease (ADPKD). The vertical axis indicates the
percentage of subjects remaining normotensive at a given age. Censored
values are indicated with a circle. The curves were significantly different
(log rank chi-square 8.53, P  0.005). The median age at diagnosis of
hypertension was 32 years for males (95% CI 30 to 33) and 34 years
for females (95% CI 33 to 35).
hypertensive (Tables 2 and 3). The types of antihyperten-
sive medications used were also no different between
the groups (data not shown).
Characteristics of male and female ADPKD
subjects with respect to unaffected parents’
blood pressure status
In contrast to the relationship between hypertension
in the affected ADPKD parents in the ADPKD male off-
spring, there was no detectable effect of the unaffected
Fig. 2. The effect of hypertension in the affected parent on the fre-
quency of hypertension in 175 male and 300 female offspring with
autosomal-dominant polycystic kidney disease (ADPKD). Both male
and female offspring were more likely to be hypertensive when the
affected parent was also hypertensive.
parent on the frequency of hypertension in the male
ADPKD offspring. The incidence of hypertension in the
male ADPKD offspring, however, was quite high whether
the unaffected parent was or was not hypertensive (89%
versus 77%, respectively, NS) (Fig. 4). Age of diagnosis
of hypertension, proteinuria, renal function, and blood
pressures were comparable in both groups (Table 4).
The situation was, however, different in the ADPKD
female offspring relative to the blood pressure status of
the unaffected parents. If the unaffected parent was hy-
pertensive, the female ADPKD offspring was more likely
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Fig. 3. Kaplan-Meier survival curves for age at diagnosis of hypertension in male and female autosomal-dominant polycystic kidney disease
(ADPKD) subjects with respect to the hypertensive status of the affected parent. (A ) In male subjects, censored values are indicated with a circle.
The curves were significantly different (log-rank chi-square 6.01, P  0.05). The median age at diagnosis of hypertension was 33 years for 154
subjects with a hypertensive affected parent (95% CI 31 to 34) and 40 years for 21 subjects with a normotensive affected parent (95% CI 33 to
51). (B ) In female subjects, censored values are indicated with a circle. The curves were significantly different (log-rank chi-square 6.43, P  0.05).
The median age at diagnosis of hypertension was 38 years for 257 subjects with a hypertensive affected parent (95% CI 36 to 41) and 50 years
for 43 subjects with a normotensive affected parent (95% CI 40 to 55).
Table 2. Characteristics of male autosomal-dominant polycystic kidney disease (ADPKD) subjects
with respect to affected ADPKD parents’ blood pressure status
Affected parent Affected parent
hypertensive normotensive P value
Number 154 21 —
Age at visit years 4111 3812 NS
Mean age at diagnosis of hypertension years 319 3613 NS
Median age at diagnosis of hypertension years (95% CI) 33 (31–34) 40 (33–51) 0.05
Father as affected parent 58% 29% 0.01
Mean renal volume cm3 1093804 1006807 NS
Systolic blood pressure mm Hg 13515 13310 NS
Diastolic blood pressure mm Hg 8611 848 NS
Mean arterial pressure mm Hg 10211 1008 NS
Urinary protein excretion mg/24 hours 374540 423585 NS
Serum creatinine mg/dL 2.11.5 2.01.4 NS
Glomerular filtration rate mL/min/1.73 m2 5630 5929 NS
Table 3. Characteristics of female autosomal-dominant polycystic kidney disease (ADPKD) subjects
with respect to affected ADPKD parents’ blood pressure status
Affected parent Affected parent
hypertensive normotensive P value
Number 257 43 —
Age at visit years 4011 4011 NS
Mean age at diagnosis of hypertension years 3311 3711 NS
Median age at diagnosis of hypertension years (95% CI) 38 (36–41) 50 (40–55) 0.05
Father as affected parent 53% 44% NS
Mean renal volume cm3 699482 607431 NS
Systolic blood pressure mm Hg 12714 12415 NS
Diastolic blood pressure mm Hg 819 8010 NS
Mean arterial pressure mm Hg 9610 9511 NS
Urinary protein excretion mg/24 hour 225331 353644 NS
Serum creatinine mg/dL 1.51.1 1.51.5 NS
Glomerular filtration rate mL/min/1.73 m2 6029 6429 NS
to be hypertensive than normotensive (69% versus 53%,
P  0.01) (Fig. 4). There was, however, no difference in
the age of diagnosis of hypertension whether the un-
affected parent was or was not hypertensive. However,
the GFR was better preserved in the offspring ADPKD
subject if the unaffected parent was normotensive as
compared to hypertensive (63  29 mL/min/1.73 m2 ver-
sus 54  27 mL/min/1.73 m2, respectively, P  0.05)
(Table 5). The age at the time of study visit was, however,
slightly younger in the ADPKD female offspring when
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Fig. 4. The effect of hypertension in the unaffected parent on the
frequency of hypertension in 175 male and 300 female offspring with
autosomal-dominant polycystic kidney disease (ADPKD). Female off-
spring were significantly more likely to be hypertensive when the unaf-
fected parent was also hypertensive; in male offspring the frequencies
were not significantly different.
the unaffected parent was normotensive (39  11 years
versus 42 11 years, P 0.05). Moreover, using analysis
of covariance to correct for age of the female offspring,
GFR was not significantly different between those with
a hypertensive versus normotensive unaffected parent
(P  NS). Logistic regression analysis modeling the
probability of hypertension given the age of the study
subjects and the hypertensive status of the unaffected
parent demonstrated that both variables had a significant
effect (age, P 0.0001; hypertensive status of unaffected
parent, P  0.05, odds ratio 1.7). In neither male nor
female ADPKD offspring were the antihypertensive
agents used significantly different between any of the
groups (data not shown).
Hypertension in both parents
A greater percentage of male offspring were hyperten-
sive if both parents were hypertensive rather than only
the affected parent, but this difference was not significant
(90% versus 80%, NS) (Table 6). In female offspring,
the difference in the percent hypertensive between those
with both parents hypertensive versus only the affected
parent hypertensive was significant (72% versus 56%,
P 0.05). Data on the characteristics of male and female
subjects with respect to the hypertensive status of both
parents are presented in Table 6.
Multivariate analysis
In both men and women, the best fitting model did not
include a significant effect of hypertension in the unaf-
fected parent nor the interaction of hypertension in both
parents. In men, the significant predictors of hyperten-
sion were hypertension in the affected parent (odds ratio
3.6, P  0.05), age of the offspring (odds ratio 1.1 per
year, 3.4 for a 10-year increase, P  0.0001) and urinary
sodium excretion in the offspring (odds ratio 1.01 per
mg/24 hours, 3.1 for a 100 mg increase, P  0.005). In
women, the significant predictors of hypertension were
hypertension in the affected parent (odds ratio 3.3, P 
0.005), age of the offspring (odds ratio 1.1 per year, 1.5
for a 10-year increase, P  0.0001) and body mass index
in the offspring (odds ratio 1.1 per k/m2, 1.4 for a 20
pound weight gain, P  0.05).
Evidence against recall or ascertainment bias
Because of the possibility of recall or ascertainment
bias since the parental information was provided by the
offspring, we compared the subjects who had no previous
diagnosis of hypertension (i.e., those diagnosed with hy-
pertension at the study visit) with those with a previous
diagnosis of hypertension. Those results showed no con-
sistent pattern; specifically, males with a history of hyper-
tension were more likely to state that their affected par-
ent was hypertensive yet less likely to state that their
non-affected parent was hypertensive; these results were
reversed in women. We also examined the 71 subjects
who were excluded because they did not know the hyper-
tensive status of their parents to see if they were less
likely to be hypertensive (i.e., if hypertensive subjects
were more likely to ask their parents whether they had
hypertension). Their incidence of hypertension was com-
parable to that of the included subjects. Thus, these anal-
yses were not supportive of recall or ascertainment bias.
DISCUSSION
The intrafamilial phenotypic variability of ADPKD
patients is not well understood. Members of the same
family have the same genetic mutation, but nevertheless
may vary considerably with respect to clinical expression
of ADPKD, including renal size and function, hyperten-
sion, and progression to ESRD. While the ADPKD clini-
cal expression is influenced by the gender and age of the
patient, there are clearly other factors involved. Even if
the normal allele undergoes mutagenesis according to
the two-hit hypothesis, the question remains why certain
members of the same family would have more “second
hits” leading to larger kidneys, hypertension, and more
rapid progression of renal functional loss than other
members of the same family.
Over the years our research group has focused on the
pathogenesis and treatment of hypertension in ADPKD
[11–13, 16–20], since it is the most treatable of the risk
factors in progression of the renal and cardiac disease
in PKD patients. Hypertension in ADPKD patients is
more frequent in males and is associated with larger kid-
neys and increased left ventricular mass index (LVMI) in
both children and adults with ADPKD [11, 13, 21, 22].
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Table 4. Characteristics of male autosomal-dominant polycystic kidney disease (ADPKD) subjects
with respect to unaffected parents’ blood pressure status
Unaffected parent Unaffected parent
hypertensive normotensive P value
Number 45 130 —
Age at visit years 4310 4012 NS
Mean age at diagnosis of hypertension years 338 3110 NS
Median age at diagnosis of hypertension years (95% CI) 34 (30–38) 33 (31–36) NS
Father as unaffected parent 44% 58% NS
Mean renal volume cm3 996559 1112873 NS
Systolic blood pressure mm Hg 13718 13413 NS
Diastolic blood pressure mm Hg 8711 8511 NS
Mean arterial pressure mm Hg 10412 10111 NS
Urinary protein excretion mg/24 hour 392491 376562 NS
Serum creatinine mg/dL 2.31.6 2.01.5 NS
Glomerular filtration rate mL/min/1.73 m2 5028 5830 NS
Table 5. Characteristics of female autosomal-dominant polycystic kidney disease (ADPKD) subjects
with respect to unaffected parents’ blood pressure status
Unaffected parent Unaffected parent
hypertensive normotensive P value
Number 90 210 —
Age at visit years 4211 3911 0.05
Mean age at diagnosis of hypertension years 3310 3411 NS
Median age at diagnosis of hypertension years (95% CI) 36 (33–44) 40 (38–44) NS
Father as unaffected parent 42% 55% 0.05
Mean renal volume cm3 759534 655447 NS
Systolic blood pressure mm Hg 12915 12613 NS
Diastolic blood pressure mm Hg 818 819 NS
Mean arterial pressure mm Hg 9710 9610 NS
Urinary protein excretion mg/24 hours 275433 230373 NS
Serum creatinine mg/dL 1.71.2 1.41.2 NS
Glomerular filtration rate mL/min/1.73 m2 5427 6329 0.05
Table 6. Characteristics of male and female autosomal-dominant polycystic kidney disease (ADPKD) subjects
with respect to both parents’ blood pressure status
Affected parent Unaffected parent
hypertensive; hypertensive;
Both parents unaffected parent affected parent Both parents
hypertensive normotensive normotensive normotensive
Males
Number 41 113 4 17
% hypertension 90 80 75 59a
Age at visit years 4310 4012 427 3713
Mean age at diagnosis of hypertension years 348 309b 256 3913
Median age at diagnosis of hypertension years (95% CI) 34 (32–36) 30 (27–32) 28 (19–42) 36 (25–41)
Females
Number 78 179 12 31
% hypertension 72 56b 50 32a
Age at visit years 4211 4012 4712 3810
Mean age at diagnosis of hypertension years 3210 3411 409 3512
Median age at diagnosis of hypertension years (95% CI) 33 (28–37) 34 (33–35) 41 (33–45) 35 (30–39)
Comparisons were made only between both parents hypertensive versus affected parent hypertensive; unaffected parent normotensive and both parents hypertensive
versus both parents normotensive.
a P  0.05, both parents hypertensive versus both parents normotensive
b P  0.05, both parents hypertensive versus affected parent hypertensive and unaffected parent normotensive
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It is also clear that ADPKD patients with hypertension
progress more rapidly to ESRD than normotensive
ADPKD patients [23]. For these reasons, it is important
to better understand the factors involved in the hyperten-
sion associated with ADPKD.
The present study tested the hypothesis that the pres-
ence of hypertension in ADPKD patients is linked to
the presence of hypertension in both the affected and
unaffected parents. Because of the role of gender in the
frequency of ADPKD hypertension, the ADPKD female
and male patients were analyzed separately. The age of
the subjects at time of study were virtually the same in
the groups analyzed, therefore the effects of parental
hypertension in the ADPKD offspring could be exam-
ined independent of gender and age. The only exception
was that the female ADPKD patients with unaffected
normotensive parents were somewhat younger.
The present results clearly demonstrate that the occur-
rence of hypertension in both male and female ADPKD
patients was significantly greater when their affected par-
ent was hypertensive. Moreover, the age of diagnosis of
hypertension, which is a reasonable available index of
age of onset, was also earlier in male and female ADPKD
patients whose affected parent was hypertensive. In the
present study, it is difficult to determine whether factors
causing hypertension or factors maintaining normoten-
sion in ADPKD patients are more important. It is inter-
esting, however, that the affected parent without hyper-
tension was significantly more likely to be the mother.
The effect of unaffected parents’ blood pressure status
on the offspring’s incidence of hypertension was also
analyzed. No relationship could be demonstrated be-
tween the unaffected parents’ blood pressure and the
occurrence of hypertension in the male offspring. In this
setting, however, the male gender effect on blood pres-
sure may have dominated and obscured any parental ef-
fect, since the overall incidence of hypertension in these
male patients was 80%. In the female ADPKD patients,
however, there was a significantly higher incidence of
hypertension when the unaffected parents were hyper-
tensive (69% versus 53%, P  0.01). This finding is in
concert with an earlier study of 58 ADPKD patients,
which demonstrated a relationship between primary hy-
pertension in the unaffected parent and a worse renal
prognosis [24]. In subjects without renal disease, parental
hypertension has been found to be predictive of high
blood pressure in offspring; however, the strength of
the association varied depending on the gender of both
parent and offspring and the age of the offspring [25, 26].
Given the high frequency of hypertension in individuals
with ADPKD, it was unknown whether the ADPKD
renal disease would obscure any influence of parental
hypertension. This turned out not to be the case.
The correlation of the presence of hypertension be-
tween the affected parent and offspring could reflect
familial clustering of disease severity, caused by the par-
ticular PKD mutation in the family, rather than the effect
of modifying genes. However, the influence of the un-
affected parent, at least in females, would suggest that
modifying genes play a role in the heritability of hyper-
tension in ADPKD.
Because the information regarding the parents’ hyper-
tensive status was obtained by the offspring, bias recall
or ascertainment bias may be an issue. However, we
examined this issue by both comparing those patients
with a previous diagnosis of hypertension with those
diagnosed at the study visit, and comparing those in-
cluded in the study with those excluded because they
did not know their parents’ hypertensive status. No con-
sistent findings suggesting recall or ascertainment bias
were observed. However, such bias cannot be totally
excluded.
CONCLUSION
The results of the present large study in 475 ADPKD
patients indicate that knowledge of the presence of pa-
rental hypertension may alert the clinician and allow
earlier detection and treatment of hypertension in off-
spring with ADPKD. This would no doubt decrease the
occurrence of LVH in ADPKD patients, an important
clinical issue since cardiovascular events are the most
important cause of death in ADPKD [27]. In our popula-
tion, 48% of hypertensive ADPKD patients have LVH
prior to ESRD [13]. The importance of LVH as a major
cause of cardiovascular events, including cardiac isch-
emia, cardiac failure, arrhythmias, and sudden death, is
well established [28–31]. Moreover, in addition to the
cardiovascular benefit, early detection and treatment of
hypertension in ADPKD may also potentially slow or
prevent the progression to ESRD in ADPKD patients.
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